Trifork Group (TRIFOR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Revenue for 2024 is expected to be flat or slightly down compared to 2023, breaking a long-standing growth trend and disappointing management expectations.
EBITDA and EBIT are both anticipated to be around EUR 10 million lower than 2023, with adjusted EBITDA guidance for 2024 at EUR 25–27m and EBIT at EUR 8–10m.
Major cost-saving initiatives have been launched, including a 10% reduction in top management salaries, no bonuses, and workforce reductions, targeting EUR 10 million in annual savings.
The company has compensated for lost revenue from major customers by onboarding new clients and expanding its pipeline, with strong growth in the US and public sector Denmark.
Guidance for 2024 was downgraded due to continued delays, weak private sector demand, and a challenging business climate.
Financial highlights
Q3 2024 revenue was EUR 47.1m, a 1.8% year-over-year decline, with organic revenue down 1.9% and inorganic growth of 2.6%.
Margins decreased, with adjusted EBITDA margin at 11.3% in Q3 and 10.9% for 9M/2024, down from 14.3% in 9M/2023.
EBIT margin for Q3 2024 was 2.4%, and for 9M/2024 was 3.0%, both down significantly year-over-year.
Net interest-bearing debt stood at EUR 49.7m, with a leverage ratio of 1.8x NIBD/adj. EBITDA.
Free cash flow for 9M/2024 was EUR 4.2m, down from EUR 16.5m in 9M/2023.
Outlook and guidance
2024 revenue guidance is EUR 205–208m, representing -1.4% to 0.0% total growth, with adjusted EBITDA guidance of EUR 25–27m and EBIT of EUR 8–10m.
EUR 10 million in annual cost savings are targeted, with the full EBITDA effect expected in 2025.
Management is confident in a Q4 rebound due to a strong pipeline, especially in the US and public sector Denmark.
Mid-term targets (2026): 15–25% annual growth, 10–15% organic growth, and 16–20% adjusted EBITDA margin.
Latest events from Trifork Group
- Record 2025 revenue, strong product growth, margin gains, and robust 2026 outlook.TRIFOR
Q4 202527 Feb 2026 - Revenue up 7.3% to EUR 220.9M, strong product growth, margin recovery, and robust outlook.TRIFOR
Q4 202527 Feb 2026 - Revenue and margins fell, but public sector momentum and Labs gains support future outlook.TRIFOR
Q2 202423 Jan 2026 - Product-driven growth, innovation in AI and digital health, and strong 2025 financial targets.TRIFOR
Danske Bank Winter Seminar presentation19 Jan 2026 - Q2 2025 revenue up 5.1%, with product focus and digital health wins fueling future growth.TRIFOR
Investor presentation16 Jan 2026 - Product-driven growth, innovation in AI, and strong 2025 financial targets define the outlook.TRIFOR
Investor presentation16 Jan 2026 - Product-led transformation, robust 2025 outlook, and strong Labs investment performance.TRIFOR
SEB Nordic Seminar presentation16 Jan 2026 - Labs portfolio value reaches EUR 84m, with strong exits and high-growth companies driving returns.TRIFOR
Investor update13 Jan 2026 - Record Q4, flat full-year, 2025 targets growth via cost savings and US/product focus.TRIFOR
Q4 20242 Dec 2025